Corcept Therapeutics, Inc. (CORT)
77.46
+4.13
(+5.63%)
USD |
NASDAQ |
Jun 09, 16:00
77.46
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Research and Development Expense (Quarterly) : 66.26M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 9.555M |
| Merck & Co., Inc. | 11.98B |
| Liquidia Corp. | 12.27M |
| Indivior Pharmaceuticals, Inc. | 9.00M |
| ANI Pharmaceuticals, Inc. | 10.60M |